Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Affymetrix Inc.

BioPhotonics
Jun 2007
Affymetrix Inc. of Santa Clara and NuGen Technologies Inc. of San Carlos, both in California, have announced an agreement to market the NuGen WT-Ovation FFPE system, enabling global gene expression analyses on archives of small and degraded formalin-fixed, paraffin-embedded (FFPE) samples using standard Affymetrix GeneChip 3' expression arrays.

In other news, Affymetrix’s Clinical Services Laboratory in West Sacramento has been granted California’s Clinical Laboratory Improvement Amendments certification. The lab offers microarray-based molecular diagnostic patient and clinical trial testing for the development of personalized tests and therapies. Based on standardized guidelines, the certification validates the lab’s methods with regard to accuracy, precision, sensitivity, calibration, control and repeatability.

Affymetrix Inc.Biophotonicsexpression arraysmicroarray-based molecular diagnosticNews & Features

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2017 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!